Potent and selective thiophene urea-templated inhibitors of S6K
Authors:
- Cyrille KuhnCKCyrille Kuhn
- Miret JuanMJMiret Juan
- Rahul SharmaRSRahul Sharma
- Brendan ConnollyBCBrendan Connolly
- Gordon AltonGAGordon Alton
- Hu LiuHLHu Liu
- Robert StantonRSRobert Stanton
- Natasha M. KablaouiNKNatasha M. Kablaoui
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (2) , 849-852
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1α activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effectMolecular Cancer Therapeutics, 2009
- Abrogation of Hyperosmotic Impairment of Insulin Signaling by a Novel Class of 1,2-Dithiole-3-thiones through the Inhibition of S6K1 ActivationMolecular Pharmacology, 2008
- Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate–activated protein kinase–p70 ribosomal S6 kinase-1 pathwayHepatology, 2007
- Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destructionDiabetologia, 2007
- hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signalingCurrent Opinion in Cell Biology, 2007
- Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1Cell Metabolism, 2006
- LY303511 (2-Piperazinyl-8-phenyl-4 H-1-benzopyran-4-one) Acts via Phosphatidylinositol 3-Kinase-Independent Pathways to Inhibit Cell Proliferation via Mammalian Target of Rapamycin (mTOR)- and Non-mTOR-Dependent MechanismsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival DeficienciesCurrent Biology, 2004
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivityNature, 2004
- The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteinsJournal of Cell Biology, 2004